Streetbeat News

Revenues

NOW

22 analysts have recently reviewed ServiceNow (NYSE:NOW), offering a mix of bullish and bearish perspectives. The average 12-month price target for NOW has been raised to $855.27, marking a 12.48% increase from the previous target. Analysts have adjusted their ratings and price targets, reflecting optimism about the company's performance and market position. ServiceNow's financial overview shows a strong revenue growth rate of 25.62% and an exceptional net margin of 12.11%, despite a below-average return on equity (ROE) of 3.98%.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 8:01 pm

TWST

Twist Bioscience (NASDAQ:TWST) has received mixed ratings from analysts, with a recent shift towards a more positive outlook. Over the past three months, 5 analysts have provided ratings, with the latest average 12-month price target for TWST being $43.6, marking a significant increase from the previous target of $31. This positive adjustment reflects analysts' growing optimism about the company's performance and market position. Twist Bioscience, a synthetic biology company, has shown a revenue growth rate of 31.81% as of December 31, 2023, despite trailing behind its industry peers. The company's financial health is highlighted by its efficient cost management, impressive ROE and ROA, and a prudent approach to debt management.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 8:00 pm

BR

Analyst ratings for Broadridge Financial Solutions (NYSE:BR) show a mix of sentiments, with recent adjustments leading to an average 12-month price target of $217.0, up from $208.00. The company, known for its investor communications and technology-driven solutions, has seen positive revenue growth but faces challenges in net margin, ROA, and debt management. Analysts from DA Davidson, Evercore ISI Group, RBC Capital, and Raymond James have provided updates, with most maintaining or raising their price targets.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 8:00 pm

CL

Recent analyst ratings for Colgate-Palmolive (NYSE:CL) show a generally positive outlook, with upgrades and raised price targets reflecting optimism about the company's performance and market position. The average 12-month price target is $91.33, indicating a 6.56% increase from the previous average of $85.71. Colgate-Palmolive's financial indicators such as revenue growth, net margin, ROE, and ROA are strong, although its high debt-to-equity ratio poses a challenge. The company's global presence and diverse product range contribute to its robust market capitalization and investor confidence.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 8:00 pm

STWD

Four analysts have recently shared their views on Starwood Prop Trust (NYSE:STWD), with sentiments ranging from bullish to indifferent. Over the past three months, there has been a shift towards more positive ratings, with three somewhat bullish and one indifferent rating currently. The 12-month price targets suggest a stable outlook with an average target of $20.88. Analyst actions include both raises and lowers in ratings and price targets, reflecting changing market dynamics and company performance. Starwood Prop Trust, a real estate investment trust, has shown a revenue growth of 19.03% but lags in net margin and ROE compared to industry averages.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:01 pm

IFF

Intl Flavors & Fragrances (NYSE:IFF) received mixed ratings from 14 analysts, with an updated average 12-month price target of $89.93, reflecting an 8.91% increase from the previous target. The company, a global leader in specialty ingredients, faces financial challenges with a -4.96% revenue decline and below-industry averages in net margin, ROE, and ROA, despite a sound debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:01 pm

PEGA

Analyst ratings for Pegasystems (NASDAQ:PEGA) over the last three months show diverse opinions, with a recent shift towards a more bullish outlook. The average 12-month price target has increased to $70.57, up from $67.00, with actions ranging from 'Maintain' to 'Raise'. Pegasystems, known for its Pega Infinity platform, has shown solid revenue growth and impressive profitability metrics, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:00 pm

BPMC

Blueprint Medicines (NASDAQ:BPMC) received mixed analyst ratings over the last three months, with a shift towards a more bullish outlook in the last 30 days. The average 12-month price target for BPMC has been raised to $95.67, significantly higher than the previous target of $56.00. Analysts from JMP Securities, Needham, Citigroup, and Barclays have updated their ratings and price targets, reflecting diverse perspectives on BPMC's market performance. The company, known for its small molecule drug pipeline for cancer and rare genetic diseases, has shown notable revenue growth and a high net margin despite challenges in debt management and efficiency metrics.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:00 pm

SHAK

Analysts have varied opinions on Shake Shack (NYSE:SHAK), with recent ratings ranging from bullish to bearish. The average 12-month price target has risen to $106.06, up 21.61% from $87.21. Analyst actions include maintaining, raising, and adjusting price targets, reflecting changing market dynamics and company performance. Shake Shack's financial performance shows solid revenue growth of 20.0% as of December 31, 2023, a net margin of 2.52%, but below-average ROE and ROA, indicating potential efficiency challenges.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:00 pm

RIO

Iron ore prices are surging due to increased demand from China, positively impacting the Australian dollar (AUD). Transaction volumes in major Chinese ports have significantly risen, with the most-traded September iron ore on China's Dalian Commodity Exchange closing at its highest in weeks. This surge is attributed to China's steel control policies, improving steel margins and expectations of increased steel production. Rio Tinto (NYSE:RIO) announced a partnership to launch an entrepreneurial hub in West Australia, focusing on mining innovation, alongside securing a $15 billion financing agreement for the Simandou iron mine in Guinea, indicating a strong focus on innovation and expansion.

Portfolio Pulse from Stjepan Kalinic

April 10, 2024 | 6:59 pm